|Title:||Inhibiting breast cancer progression by targeting SND1 using a novel peptide identified from phage display|
|Advisors:||Chow, Larry (ABCT)|
|Subject:||Hong Kong Polytechnic University -- Dissertations|
Breast -- Cancer -- Treatment
|Department:||Department of Applied Biology and Chemical Technology|
|Pages:||xxi, 163 pages : color illustrations|
|Abstract:||Breast cancer is the most common cancer in women, causing 626,679 deaths worldwide in 2018. SND1 is a multifunctional oncoprotein overexpressed in almost all cancers, especially in advanced and metastatic cases. SND1-MTDH interaction contributes to the initiation and progression of breast cancer, making it a promising target for breast cancer treatment. In this study, recombinant SN1/2 domain of SND1 was expressed in E.coli and purified with HisTrap affinity column. SN1/2 was used as bait in a phage display screening. After 4 rounds of screening, 20 phages were randomly picked and sequenced. Amino acids W and Y were found to be highly enriched in these phages. The most repeated peptide 4-2 was demonstrated to have high binding affinity towards SN1/2. Peptide 4-2 could disrupt 22-mer MTDH peptide from interacting with SN1/2 in ELISA assay and could also disrupt SND1-MTDH full-length protein interaction in co-immunoprecipitation assay. An RR-TAT cell penetrating peptide was attached to the N-terminus of peptide 4-2 to generate CPP-4-2 peptide. CPP-4-2 peptide could penetrate and preferentially kill breast cancer cells by inducing apoptosis compared to other cancer types or normal cells. Mechanistic investigation suggested that peptide 4-2 could interact with SND1 and disrupt SND1-MTDH interaction, which probably lead to the degradation of SND1. Overexpression of SND1 could reduce the cytotoxicity of peptide 4-2 to breast cancer cells, indicating that the disruption of SND1-MTDH interaction and subsequent degradation of SND1 by peptide 4-2 was the possible reason for breast cancer cell death. It was found that peptide 4-2 could regulate Akt pathway by upregulating p-Akt S473 and degrading Akt. The degradation of Akt by peptide 4-2 was proteasome-dependent and was partially dependent on the phosphorylation of Akt at S473. On the other hand, peptide 4-2 could also regulate another SND1 downstream target NF-κB2 by enhancing the transcription of pro-apoptotic NF-κB2. The degradation of Akt and the enhanced transcription of NF-κB2 induced by peptide 4-2 might be the reasons for breast cancer cell death. Mutational analysis suggested that W10 but not Y4 or Y11 was essential in the activities of peptide 4-2, including cytotoxicity, SND1-interaction, SND1 downregulation, Akt degradation and NF-κB2 activation. In summary, peptide 4-2 selectively killed breast cancer cells by inducing apoptosis possibly through interacting with SND1, disrupting SND1-MTDH interaction and inducing SND1 degradation. Peptide 4-2 could also affect SND1 downstream targets, Akt and NF-κB2 by degrading Akt and enhancing the transcription of pro-apoptotic NF-κB2, which possibly lead to breast cancer cell death. W10 rather than Y4 or Y11 was the essential amino acid in the activities of peptide 4-2.|
|Rights:||All rights reserved|
Files in This Item:
|991022289512703411.pdf||For All Users||4.68 MB||Adobe PDF||View/Open|
As a bona fide Library user, I declare that:
- I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
- I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
- I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.
By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.
Please use this identifier to cite or link to this item: